AU774760B2 - Ucp5 - Google Patents

Ucp5 Download PDF

Info

Publication number
AU774760B2
AU774760B2 AU14667/00A AU1466700A AU774760B2 AU 774760 B2 AU774760 B2 AU 774760B2 AU 14667/00 A AU14667/00 A AU 14667/00A AU 1466700 A AU1466700 A AU 1466700A AU 774760 B2 AU774760 B2 AU 774760B2
Authority
AU
Australia
Prior art keywords
seq
ucp5
leu
nucleic acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU14667/00A
Other languages
English (en)
Other versions
AU1466700A (en
Inventor
Sean Adams
James Pan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU1466700A publication Critical patent/AU1466700A/en
Application granted granted Critical
Publication of AU774760B2 publication Critical patent/AU774760B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU14667/00A 1998-11-30 1999-11-03 Ucp5 Expired AU774760B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US11028698P 1998-11-30 1998-11-30
US60/110286 1998-11-30
US12958399P 1999-04-16 1999-04-16
US60/129583 1999-04-16
US14388699P 1999-07-15 1999-07-15
US60/143886 1999-07-15
PCT/US1999/025947 WO2000032624A2 (en) 1998-11-30 1999-11-03 Uncoupling protein 5 - ucp5

Publications (2)

Publication Number Publication Date
AU1466700A AU1466700A (en) 2000-06-19
AU774760B2 true AU774760B2 (en) 2004-07-08

Family

ID=27380826

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14667/00A Expired AU774760B2 (en) 1998-11-30 1999-11-03 Ucp5

Country Status (8)

Country Link
US (2) US6967245B2 (https=)
EP (1) EP1135496B1 (https=)
JP (1) JP2002533062A (https=)
AT (1) ATE492640T1 (https=)
AU (1) AU774760B2 (https=)
CA (1) CA2349839C (https=)
DE (1) DE69943058D1 (https=)
WO (1) WO2000032624A2 (https=)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775662A (en) 1983-03-07 1988-10-04 Smithkline Beckman Corporation Leukotriene antagonists
US5010003A (en) 1983-04-25 1991-04-23 Genentech, Inc. Use of yeast homologous signals to secrete heterologous proteins
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
US5663304A (en) 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US5407810A (en) 1993-08-20 1995-04-18 Genentech, Inc. Aqueous multiple-phase isolation of polypeptide
US5861485A (en) 1994-08-23 1999-01-19 Millennium Pharmaceuticals, Inc. Polypeptides involved in body weight disorders, including obesity
US6534631B1 (en) * 1998-07-15 2003-03-18 Human Genome Sciences, Inc. Secreted protein HT5GJ57
AU7466198A (en) * 1997-04-09 1998-10-30 Beth Israel Deaconess Medical Center Ucp3: an uncoupling protein homologue
JP2002502240A (ja) 1997-05-20 2002-01-22 メルク エンド カンパニー インコーポレーテッド ヒト脱共役タンパク質３
WO2000004037A1 (en) 1998-07-14 2000-01-27 Amylin Pharmaceuticals, Inc. Uncoupling protein 4 (ucp-4) and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EMBL ACCESSION NUMBER AF 078544 *

Also Published As

Publication number Publication date
JP2002533062A (ja) 2002-10-08
CA2349839C (en) 2013-10-08
EP1135496B1 (en) 2010-12-22
AU1466700A (en) 2000-06-19
WO2000032624A3 (en) 2000-11-09
WO2000032624A2 (en) 2000-06-08
EP1135496A2 (en) 2001-09-26
DE69943058D1 (de) 2011-02-03
US20030077749A1 (en) 2003-04-24
US20080312417A1 (en) 2008-12-18
CA2349839A1 (en) 2000-06-08
US6967245B2 (en) 2005-11-22
ATE492640T1 (de) 2011-01-15

Similar Documents

Publication Publication Date Title
IL205793A (en) Polymeric-2 Polymeric Polypeptide of Vertebrates Spotted to Heterologous Amino Acid Sequence
EP2330198A1 (en) IL-1 related polypeptides
US7642242B2 (en) PRO34128 polypeptides
EP1294881B1 (en) Control of metabolism with compositions of the human 2-oxoglutarate carrier
AU774760B2 (en) Ucp5
US8648174B2 (en) Ucp4
EP1506215B1 (en) Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
US7342102B2 (en) Uncoupling protein 5 (UCP5)
AU2001271395A1 (en) Control of metabolism with compositions of the human 2-oxoglutarate carrier
US20080166763A1 (en) Human toll homologues
EP1659131B1 (en) Polypeptides and nucleic acids encoding the same
US20080299610A1 (en) Human toll homologue
EP1209168B1 (en) PRO243 polypeptides and nucleic acids encoding the same
EP1207168B1 (en) Polypeptides and nucleic acids encoding the same
JP2002533062A5 (https=)
EP1464654A2 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1475439A2 (en) Control of metabolism with compositions of the human 2-oxoglutarate carrier

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired